Monogram Orthopaedics Inc
NASDAQ:MGRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
BMV:AZNN
|
UK |
|
E
|
Eurocash SA
WSE:EUR
|
PL |
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
G
|
Geumhwa PSC Co Ltd
KOSDAQ:036190
|
KR |
Monogram Orthopaedics Inc
Research & Development
Monogram Orthopaedics Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Monogram Orthopaedics Inc
NASDAQ:MGRM
|
Research & Development
-$8.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cadre Holdings Inc
NYSE:CDRE
|
Research & Development
-$11.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Glaukos Corp
NYSE:GKOS
|
Research & Development
-$150.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-20%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
UFP Technologies Inc
NASDAQ:UFPT
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alphatec Holdings Inc
NASDAQ:ATEC
|
Research & Development
-$76.3m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-16%
|
|
Monogram Orthopaedics Inc
Glance View
Monogram Orthopaedics Inc is a US-based company operating in industry. The company is headquartered in Brooklyn, New York. The company went IPO on 2023-05-18. Monogram Orthopaedics Inc. (Monogram) is engaged in developing a product solution architecture for mass personalization of orthopedic implants by linking three-dimensional (3D) printing and robotics via automated digital image analysis algorithms. Its primary business is to market orthopedic implants insertable with its orthopedic robot. The company has a navigated robot prototype that can optically track a simulated surgical target and execute optimized auto-generated cut paths for precision insertion of implants in synthetic bone specimens. These implants and cut paths are generated with Monogram software algorithms. The Monogram technology platform consists of a workflow to prepare a patient-specific surgical plan from a computed tomography scan. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
See Also
What is Monogram Orthopaedics Inc's Research & Development?
Research & Development
-8.8m
USD
Based on the financial report for Dec 31, 2024, Monogram Orthopaedics Inc's Research & Development amounts to -8.8m USD.
What is Monogram Orthopaedics Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-19%
Over the last year, the Research & Development growth was 17%. The average annual Research & Development growth rates for Monogram Orthopaedics Inc have been -19% over the past three years .